Furthermore, various studies revealed the deregulated expression level of GRHL2 is related to the initiation, tumorigenesis, development, progression, and prognosis of various cancers, including breast cancer, gastric cancer, colon cancer, oral squamous cell carcinoma, and liver cancer [38, 39]. This evidence concerns the gene GRHL2 and cancer.